Medical Mutual of Ohio v. AbbVie Inc., et al
| ACTAVIS PLC, AUXILIUM PHARMACEUTICALS, INC., ELI LILLY AND COMPANY, ABBOTT LABORATORIES INC. and ABBVIE INC. |
| MEDICAL MUTUAL OF OHIO |
| 19-1500 |
| March 19, 2019 |
| U.S. Court of Appeals, Seventh Circuit |
| Other |
Opinions
We have the following opinions for this case:
| Description |
|---|
| Medical Mutual of Ohio v. AbbVie Inc. |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 2, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 18
ORDER re: Defendants-appellees' joint motion for case management conference. IT IS ORDERED that briefing in this appeal is SUSPENDED pending further court order. CMD [18] [7002196] [19-1500] (VG) [Entered: 05/02/2019 02:33 PM]
|
| Filing 17 Joint motion filed by Appellee Eli Lilly and Company Appellees' Request for Case Management Conference. [17] [7002173] [19-1500] (Stanley, David) [Entered: 05/02/2019 01:42 PM] |
| Filing 16 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Janet H. Kwuon for Appellee Eli Lilly and Company. for Lilly USA, LLC; Acrux Commercial Party LTD; and Acrux DDS Party LTD. [16] [7001653] (L-No; E-No; R-No) [19-1500] (Kwuon, Janet) [Entered: 04/30/2019 07:58 PM] |
| Filing 15 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney David E. Stanley for Appellee Eli Lilly and Company. for Lilly USA, LLC; Acrux Commercial Party LTD; and Acrux DDS Party LTD. [15] [7001652] (L-Yes; E-Yes; R-Yes) [19-1500]--[Edited 05/01/2019 by PS - to reflect termination and addition of counsel] (Stanley, David) [Entered: 04/30/2019 07:16 PM] |
| Filing 14 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Katy E. Koski for Appellee Actavis Plc. for Actavis, Inc. n/k/a Allergan Finance, LLC; Actavis Pharma, Inc.; Watson Laboratories, Inc. n/k/a Actavis Laboratories UT, Inc.; and Anda, Inc.. [14] [6997792] (L-No; E-Yes; R-No) [19-1500]-[Edited 04/15/2019 by VG - to reflect addition of counsel] (Koski, Katy) [Entered: 04/12/2019 03:20 PM] |
| Filing 13 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney David B. Goroff for Appellee Actavis Plc. for Actavis, Inc. n/k/a Allergan Finance, LLC; Actavis Pharma, Inc.; Watson Laboratories, Inc. n/k/a Actavis Laboratories UT, Inc., and Anda, Inc.. [13] [6997440] (L-No; E-Yes; R-No) [19-1500] (Goroff, David) [Entered: 04/11/2019 03:39 PM] |
| Filing 12 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney James W. Matthews for Appellee Actavis Plc. for Actavis, Inc., n/k/a Allergan Finance, LLC, Actavis Pharma, Inc., Watson Laboratories, Inc., n/k/a Actavis Laboratories UT, Inc., and Anda, Inc.. [12] [6997418] (L-Yes; E-Yes; R-No) [19-1500] --[Edited 04/11/2019 by AP- to reflect addition of counsel] (Matthews, James) [Entered: 04/11/2019 03:19 PM] |
| Filing 11 Added Attorney(s) Robert J. Katerberg for party(s) Appellee Auxilium Pharmaceuticals, Inc., in case 19-1500 per disclosure statement. Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Robert J. Katerberg for Appellee Auxilium Pharmaceuticals, Inc. Additional Parties: Endo Pharmaceuticals Inc. [11] [6996779] (L-Yes; E-Yes; R-No) [19-1500]--[Edited 04/09/2019 by AD to reflect the addition of counsel.] (Katerberg, Robert) [Entered: 04/09/2019 04:37 PM] |
| Filing 10 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Andrew K. Solow for Appellee Auxilium Pharmaceuticals, Inc.. Additional Parties: Endo Pharmaceuticals Inc.. [10] [6996776] (L-Yes; E-Yes; R-No) [19-1500] (Solow, Andrew) [Entered: 04/09/2019 04:28 PM] |
| Filing 9 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Jonah M. Knobler for Appellees Abbott Laboratories Inc. and AbbVie Inc.. for Abbott Products Inc.. [9] [6996715] (L-No; E-Yes; R-No) [19-1500] -[Edited 04/09/2019 by AP- to reflect the addition of counsel] (Knobler, Jonah) [Entered: 04/09/2019 03:25 PM] |
| Filing 8 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney William F. Cavanaugh, Jr. for Appellees AbbVie Inc. and Abbott Laboratories Inc.. for Abbott Products Inc.. [8] [6996704] (L-Yes; E-Yes; R-No) [19-1500] (Cavanaugh, William) [Entered: 04/09/2019 03:13 PM] |
| Filing 7 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney David E. Stanley, Janet H. Kwuon and Lisa M. Baird of Reed Smith LLP for Appellee Eli Lilly and Company. for Lilly USA, LLC; Acrux Commercial Party LTD.; and Acrux DDS Party LTD.. [7] [6996587] (L-Yes; E-Yes; R-Yes) [19-1500] [Edited 04/09/2019 by CAG to reflect the addition of counsel.] (Baird, Lisa) [Entered: 04/09/2019 12:55 PM] |
| Filing 6 Amended Docketing Statement filed by Appellant Medical Mutual of Ohio. Prior or Related proceedings: No. [6] [6996253] [19-1500] (Simmer, W.) [Entered: 04/08/2019 02:45 PM] |
|
Filing 5
ORDER: In the present case, appellant claims that the district court had jurisdiction, in part, based on the Class Action Fairness Act. See 28 U.S.C. 1332 (d). Appellants Circuit Rule 3(c) docketing statement, however, fails to identify the state of citizenship of at least one plaintiff and at least one defendant; it is insufficient to state that there is minimal diversity of citizenship. Accordingly, Appellant shall file a complete statement of jurisdiction that includes the omitted information. The statement is due on or before 04/09/2019. (See order for further details). DW [5] [5] [6994792] [19-1500] (MM) [Entered: 04/02/2019 12:44 PM]
|
| Filing 4 Docketing Statement filed by Appellant Medical Mutual of Ohio. Prior or Related proceedings: No. [4] [6994499] [19-1500] (Simmer, W.) [Entered: 04/01/2019 02:39 PM] |
|
Filing 3
ORDER: A review of the short record reveals that this appeal involves more than one appellee represented by different counsel. Counsel for appellees are encouraged to file a joint brief and appendix or adopt parts of a co-appellee's brief. The parties are reminded that redundant and uncoordinated briefing will be stricken. See United States v. Torres, 170 F.3d 749 (7th Cir. 1999); United States v. Ashman, 964 F.2d 596 (7th Cir. 1992). DW [6992311] [3] [6992311] [19-1500] (CAG) [Entered: 03/21/2019 10:18 AM]
|
| Filing 2 THIS CAUSE CONSISTS OF MORE THAN 5 PARTIES FOR EITHER SIDE. The following are those parties to this cause as reflected on the District Court docket, yet are not reflected on the Appellate docket/caption for administrative purposes: APPELLEES: Abbott Products, Inc., Solvay America, Inc., Solvay North America, LLC. Solvay Pharmaceuticals, Inc., Solvay Pharmaceuticals Sarl, Solvway, S.A., Lilly USA, Inc., Acrux, Actavis, Inc.,Watson Pharmaceuticals. Watson Labratories, Endo Pharmaceuticals, Anda, Inc., GlaxoSmithKline, LLC, Unimed Pharmaceuticals, LLC, Acrux Commericals, Acrux DDS, Ltd., Solvay Pharmaceuticals. [2] [6992004] [19-1500] (AP) [Entered: 03/20/2019 10:41 AM] |
| Filing 1 Private civil case docketed. Fee paid. Docketing Statement due for Appellant Medical Mutual of Ohio by 03/25/2019. Transcript information sheet due by 04/02/2019. Appellant's brief due on or before 04/29/2019 for Medical Mutual of Ohio [1] [6991997] [19-1500] (AP) [Entered: 03/20/2019 10:30 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
